Skip to content
PICO Portalanswers from OpenAlex

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer

PaperCitations, authors & open-access status

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer have?

PICO Portalcitation count

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has 155 citations in the OpenAlex counts PICO Portal stores.

When was TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer published?

PICO Portalyear

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has 2014 year in the PICO Portal index.

What is the open-access status of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

PICO Portaloa status

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer has bronze oa status in the PICO Portal index.

What is the DOI of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

PICO Portaldoi

The DOI for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

What is the PMID of TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

PICO Portalpmid

The PMID for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

What is the OpenAlex record for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer?

PICO Portalopenalex

The OpenAlex for TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial